The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Gardnerella


High impact information on Gardnerella


Chemical compound and disease context of Gardnerella


Biological context of Gardnerella


Anatomical context of Gardnerella


Gene context of Gardnerella


Analytical, diagnostic and therapeutic context of Gardnerella


  1. Anaerobic bacteria in nonspecific vaginitis. Spiegel, C.A., Amsel, R., Eschenbach, D., Schoenknecht, F., Holmes, K.K. N. Engl. J. Med. (1980) [Pubmed]
  2. Metronidazole metabolite and Gardnerella vaginalis (Corynebacterium vaginale). Baldson, M.J., Jackson, D. Lancet (1981) [Pubmed]
  3. Impairment of the mucosal immune system: IgA and IgM cleavage detected in vaginal washings of a subgroup of patients with bacterial vaginosis. Cauci, S., Monte, R., Driussi, S., Lanzafame, P., Quadrifoglio, F. J. Infect. Dis. (1998) [Pubmed]
  4. Nonoxynol-9: differential antibacterial activity and enhancement of bacterial adherence to vaginal epithelial cells. Hooton, T.M., Fennell, C.L., Clark, A.M., Stamm, W.E. J. Infect. Dis. (1991) [Pubmed]
  5. Local and systemic cytokine levels in relation to changes in vaginal flora. Hedges, S.R., Barrientes, F., Desmond, R.A., Schwebke, J.R. J. Infect. Dis. (2006) [Pubmed]
  6. Sensitivity of Gardnerella vaginalis to metabolites of metronidazole and tinidazole. Shanker, S., Munro, R. Lancet (1982) [Pubmed]
  7. Pore-forming and haemolytic properties of the Gardnerella vaginalis cytolysin. Cauci, S., Monte, R., Ropele, M., Missero, C., Not, T., Quadrifoglio, F., Menestrina, G. Mol. Microbiol. (1993) [Pubmed]
  8. Induction of tumor necrosis factor- alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. Zariffard, M.R., Novak, R.M., Lurain, N., Sha, B.E., Graham, P., Spear, G.T. J. Infect. Dis. (2005) [Pubmed]
  9. In vitro activities of Garenoxacin (BMS 284756) against 108 clinical isolates of Gardnerella vaginalis. Goldstein, E.J., Citron, D.M., Merriam, C.V., Warren, Y.A., Tyrrell, K.L., Fernandez, H.T. Antimicrob. Agents Chemother. (2002) [Pubmed]
  10. Identification of a human lactoferrin-binding protein in Gardnerella vaginalis. Jarosik, G.P., Land, C.B. Infect. Immun. (2000) [Pubmed]
  11. Susceptibility of Gardnerella vaginalis to cephradine. Goldstein, E.J., Kwok, Y.Y., Sutter, V.L. Antimicrob. Agents Chemother. (1983) [Pubmed]
  12. In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens. Bowie, W.R., Shaw, C.E., Chan, D.G., Boyd, J., Black, W.A. Antimicrob. Agents Chemother. (1986) [Pubmed]
  13. The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin. King, A., Shannon, K., Phillips, I. J. Antimicrob. Chemother. (1985) [Pubmed]
  14. Sodium polyanetholesulfonate in the identification of Gardnerella vaginalis. Jones, B.M. J. Clin. Microbiol. (1985) [Pubmed]
  15. Biotypes of Gardnerella vaginalis. Piot, P., Van Dyck, E., Peeters, M., Hale, J., Totten, P.A., Holmes, K.K. J. Clin. Microbiol. (1984) [Pubmed]
  16. Bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and metronidazole susceptibility. Simoes, J.A., Aroutcheva, A., Heimler, I., Shott, S., Faro, S. Am. J. Obstet. Gynecol. (2001) [Pubmed]
  17. Pharmacokinetics of metronidazole and its principal metabolites and their activity against Gardnerella vaginalis. Easmon, C.S., Ison, C.A., Kaye, C.M., Timewell, R.M., Dawson, S.G. The British journal of venereal diseases. (1982) [Pubmed]
  18. Influence of metronidazole treatment on the vaginal microbiological flora. Fredricsson, B., Nord, C.E. Scandinavian journal of infectious diseases. Supplementum. (1983) [Pubmed]
  19. Protein-kinase-C-independent activation of arachidonate release and prostaglandin E2 formation in macrophages interacting with certain bacteria. Svensson, U., Holst, E., Sundler, R. Eur. J. Biochem. (1991) [Pubmed]
  20. Detection of Gardnerella vaginalis in the vagina and amniotic fluid using the polymerase chain reaction. Lin, H.M., Tsui, M.S., Tu, F.C. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. (2000) [Pubmed]
  21. Identification of Gardnerella vaginalis with the API 20 Strep system. Human, R.P., Tillotson, G.S. J. Clin. Microbiol. (1985) [Pubmed]
  22. Evaluation of affirm VP Microbial Identification Test for Gardnerella vaginalis and Trichomonas vaginalis. Briselden, A.M., Hillier, S.L. J. Clin. Microbiol. (1994) [Pubmed]
  23. Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora. Briselden, A.M., Moncla, B.J., Stevens, C.E., Hillier, S.L. J. Clin. Microbiol. (1992) [Pubmed]
  24. Identification of Neisseria spp., Haemophilus spp., and other fastidious gram-negative bacteria with the MicroScan Haemophilus-Neisseria identification panel. Janda, W.M., Bradna, J.J., Ruther, P. J. Clin. Microbiol. (1989) [Pubmed]
  25. Development of a species-specific polymerase chain reaction assay for Gardnerella vaginalis. van Belkum, A., Koeken, A., Vandamme, P., van Esbroeck, M., Goossens, H., Koopmans, J., Kuijpers, J., Falsen, E., Quint, W. Mol. Cell. Probes (1995) [Pubmed]
  26. Humoral circulatory immune response to Gardnerella vaginalis. Ghione, M., Clerici, P.A., Piragine, G., Magliano, E. J. Clin. Microbiol. (1989) [Pubmed]
  27. Fatty acid, polar lipid and wall amino acid composition of Gardnerella vaginalis. O'Donnell, A.G., Minnikin, D.E., Goodfellow, M., Piot, P. Arch. Microbiol. (1984) [Pubmed]
  28. A placebo-controlled, double-blind comparison of tinidazole and triple sulfonamide cream for the treatment of nonspecific vaginitis. Piot, P., Van Dyck, E., Godts, P., Vanderheyden, J. Am. J. Obstet. Gynecol. (1983) [Pubmed]
  29. Metronidazole pessaries compared with placebo in the treatment of bacterial vaginosis. Bro, F. Scandinavian journal of primary health care. (1990) [Pubmed]
  30. Treatment of the Gardnerella vaginalis syndrome. A controlled, double-blind study comparing pivampicillin and metronidazole. Hansen, J.G., Schmidt, H. Scandinavian journal of primary health care. (1985) [Pubmed]
WikiGenes - Universities